Wire by Fusion42
Fusion42 Scout Raise
The Debrief & Outliers
Regulatory RadarWorkday Debrief · Mon 09:00 UTCSector Deep DiveWorkday Debrief · Tue 09:00 UTCGeo PulseWorkday Debrief · Wed 09:00 UTCOperating ConditionsWorkday Debrief · Thu 09:00 UTCWeekly BriefingWorkday Debrief · Fri 09:00 UTCWTF Happened This WeekSat 09:00 UTC · 3σ outliers
Benchmarks
Benchmarks HomeBy News TypeBy RegionBy Sector
AI WeeklyAbout

Switch product

Fusion42RaiseScoutWire

The Debrief & Outliers

All editionsRegulatory RadarWorkday Debrief · Mon 09:00 UTCSector Deep DiveWorkday Debrief · Tue 09:00 UTCGeo PulseWorkday Debrief · Wed 09:00 UTCOperating ConditionsWorkday Debrief · Thu 09:00 UTCWeekly BriefingWorkday Debrief · Fri 09:00 UTCWTF Happened This WeekSat 09:00 UTC · 3σ outliers

Database & benchmarks

Benchmarks HomeBy News TypeBy RegionBy SectorStories

Account

Sign in
← Back

Wire · opportunities

Inside J&J's OTTAVA™ Robotic Surgical System development

8 October 2026 · By · Wire by Fusion42

Published

8 October 2026

Topic

opportunities

◆ Sectors

Medtech

◆ Geography

United States

◆ Source

Read at jnj.com →

◆ Verified

Fusion42 · 10 October 2026 · Fusion42 review

Johnson & Johnson's OTTAVA™ Robotic Surgical System received FDA market authorization in July 2026 for multiple upper abdomen procedures. The system integrates four robotic arms directly into the operating table, offering significant space savings and operational efficiencies, and connects to the Polyphonic™ Digital Ecosystem for enhanced surgical data and insights.

This Wire brief sits within Fusion42's coverage of Medtech.

◆ ◆ The Wire takeaway

Surgeons now face a fundamentally different robotic platform that redefines operating room space and workflow. You need to explore how integrating OTTAVA™ can boost procedural efficiency and data use to stay competitive in surgical care delivery.

◆ Coverage

1 source · 8 Oct 2026

◆ Related on Wire

◆ Topics

Medtechrobotic-surgerymedtechFDA-approvalsurgical-innovationdigital-health